GlaxoSmithKline PLC (GSK)

Add to Watchlists
Create an Alert
40.63 +0.13  +0.32% NYSE Oct 23, 16:59 Delayed 2m USD

GlaxoSmithKline PLC Enterprise Value:

130.88B for Oct. 22, 2018
View 4,000+ financial data types
Browse...
View Full Chart

GlaxoSmithKline PLC Enterprise Value Chart

Export Data
Save Image
Print Image

GlaxoSmithKline PLC Historical Enterprise Value Data

View and export this data going back to 1976. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Oct. 22, 2018 130.88B
Oct. 19, 2018 131.80B
Oct. 18, 2018 128.68B
Oct. 17, 2018 129.00B
Oct. 16, 2018 129.15B
Oct. 15, 2018 126.87B
Oct. 12, 2018 125.45B
Oct. 11, 2018 125.85B
Oct. 10, 2018 127.73B
Oct. 9, 2018 128.33B
Oct. 8, 2018 127.91B
Oct. 5, 2018 129.17B
Oct. 4, 2018 130.04B
Oct. 3, 2018 130.86B
Oct. 2, 2018 130.07B
Oct. 1, 2018 129.77B
Sept. 28, 2018 130.06B
Sept. 27, 2018 130.91B
Sept. 26, 2018 130.96B
Sept. 25, 2018 130.53B
Sept. 24, 2018 130.14B
Sept. 21, 2018 130.39B
Sept. 20, 2018 129.32B
Sept. 19, 2018 128.52B
Sept. 18, 2018 128.72B
   
Sept. 17, 2018 127.68B
Sept. 14, 2018 127.19B
Sept. 13, 2018 127.98B
Sept. 12, 2018 128.05B
Sept. 11, 2018 127.14B
Sept. 10, 2018 127.90B
Sept. 7, 2018 128.65B
Sept. 6, 2018 129.10B
Sept. 5, 2018 129.96B
Sept. 4, 2018 130.48B
Aug. 31, 2018 130.88B
Aug. 30, 2018 132.71B
Aug. 29, 2018 133.58B
Aug. 28, 2018 133.03B
Aug. 27, 2018 133.33B
Aug. 24, 2018 132.81B
Aug. 23, 2018 132.51B
Aug. 22, 2018 133.45B
Aug. 21, 2018 133.35B
Aug. 20, 2018 132.93B
Aug. 17, 2018 132.73B
Aug. 16, 2018 131.69B
Aug. 15, 2018 130.78B
Aug. 14, 2018 129.14B
Aug. 13, 2018 129.06B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

GSK Enterprise Value Benchmarks

Benchmarks
AstraZeneca PLC 117.57B
Sanofi SA 102.41B
Amgen Inc 133.27B

GSK Enterprise Value Range, Past 5 Years

Minimum 109.07B Dec 06 2017
Maximum 161.09B Apr 29 2014
Average 129.52B

GSK Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("GSK", "enterprise_value")
  • Last 5 data points: =YCS("GSK", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.